Aurinia Pharmaceuticals AUPH Market capitalization

Market capitalization at other companies

Rogers CorporationROG

$2.92B+129%

Vera TherapeuticsVERA

$2.87B+87.5%

ANI PharmaceuticalsANIP

$1.88B+29.8%

Ultragenyx PharmaceuticalRARE

$3.29B-6.4%

Theravance BiopharmaTBPH

$835.73M+89.2%

Opko HealthOPK

$1.13B+10.7%

FAQ

What is Aurinia Pharmaceuticals's market capitalization?

Aurinia Pharmaceuticals (AUPH) reported market capitalization of $2.18B in Q2 2026.

How has Aurinia Pharmaceuticals's market capitalization changed year-over-year?

Aurinia Pharmaceuticals's market capitalization increased by 100.7% year-over-year, from $1.09B to $2.18B.

What is the long-term trend for Aurinia Pharmaceuticals's market capitalization?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's market capitalization has grown at a 1.2% compound annual growth rate (CAGR), from $1.98B to $2.1B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.